Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Is Merrimack Pharmaceuticals Worth More Than $700 Million?
Motley Fool
Monday, May 5, 2014 - 5:02pm
tags:
Merrimack Pharmaceuticals, pancreatic cancer, MM-398, Gemzar, Eli Lilly, Celgene, Abraxane
Vivus Earnings On Tap
Seeking Alpha
Monday, May 5, 2014 - 4:59pm
tags:
earnings, Vivus
Celgene: Do The Revlimid Polymorph And Use Patents Matter?
Seeking Alpha
Monday, May 5, 2014 - 12:09pm
tags:
Celgene, Revlimid
Narrower-than-Expected Loss at Seattle Genetics
Yahoo/Zacks.com
Monday, May 5, 2014 - 11:44am
tags:
earnings, Seattle Genetics
Earnings Beat at Pharmacyclics, Guidance Pulls Down Stock
Yahoo/Zacks.com
Monday, May 5, 2014 - 11:32am
tags:
earnings, Pharmacyclics
Pfizer's 'weak' Q1 numbers bolster case for AZ buy--and post-merger split, too
Fierce Pharma
Monday, May 5, 2014 - 10:22am
tags:
earnings, M&A, Pfizer, AstraZeneca
Monday’s Top Health Care Stories: Pfizer, Auxilium, and Regeneron
Motley Fool
Monday, May 5, 2014 - 10:15am
tags:
Pfizer, Auxilium, Regeneron, earnings, Avalanche Biotechnologies
Clinical Trial Results Indicate Acthar May Significantly Reduce Disease Activity in Patients with Systemic Lupus Erythematosus
Yahoo
Monday, May 5, 2014 - 10:01am
tags:
SLE, H.P. Acthar Gel, Questcor Pharmaceuticals
Biotech: a More Encouraging Chart
Barron's
Monday, May 5, 2014 - 9:57am
tags:
biotech
Idenix's Q1 Loss Widens
Yahoo/Zacks.com
Monday, May 5, 2014 - 9:56am
tags:
earnings, Idenix
AstraZeneca's tarnished R&D image haunts its fight against Pfizer
Fierce Biotech
Monday, May 5, 2014 - 9:47am
tags:
R&D, AstraZeneca, Pfizer, M&A
Abbott taps Morgan Stanley to sell mature products - sources
Reuters
Monday, May 5, 2014 - 9:45am
tags:
Abbott Laboratories, M&A
Apple on medical tech hiring spree, a possible hint of iWatch plans
Reuters
Monday, May 5, 2014 - 8:30am
tags:
Apple, devices, iWatch
Advaxis, Inc. - “3 for 3 on Orphan Drug Requests”
Yahoo
Monday, May 5, 2014 - 8:28am
tags:
Advaxis, orphan drugs, ADXS-HPV, ADXS-cHER2
Why Merck Is Still A Big Pharma Kingpin
Seeking Alpha
Monday, May 5, 2014 - 8:26am
tags:
Merck, Bristol-Myers Squibb, Gilead Sciences, Roche, MK-3475, hepatitis C
GlaxoSmithKline: Bringing Focus To The Business
Seeking Alpha
Monday, May 5, 2014 - 7:53am
tags:
GSK, Novartis, restructuring
Drugmaker Pfizer's 1Q profit drops 15 pct as generic competition, other factors cut sales
Yahoo/AP
Monday, May 5, 2014 - 7:52am
tags:
earnings, Pfizer
Pfizer expected to be patient in face of AstraZeneca rejection
Yahoo/Reuters
Monday, May 5, 2014 - 7:51am
tags:
Pfizer, AstraZeneca, M&A
Ian Read: the pragmatist out to transform the drugs industry
Financial Times, UK
Sunday, May 4, 2014 - 12:00pm
tags:
Pfizer, Ian Read
Why Sovaldi shouldn't cost $84,000
Modern Healthcare
Sunday, May 4, 2014 - 11:59am
tags:
Sovaldi, hepatitis C, hepatitis, Gilead Sciences

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.